<html xmlns="http://www.w3.org/1999/xhtml"> <head> <style type="text/css">
      	     		 
      	    a                          {background : #ffffff; }
      	    article                    {border-style : dotted; border-width : 2px; }
		 	
		 	div                        {background : #ffffcc;}
		 	div.abstract-title         {font-weight : bold ; font-size : 16pt;}
		 	div.ack                    {border-style : solid ; border-color : red; margin : 2em; }
		 	div.article-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.boxed-text             {margin : 5em; border-style : solid;}
		 	div.contrib-group          {margin : 1em; }
		 	div.fig                    {border-style : solid; border-width : 2px; margin : 2em; }
		 	div.funding                {font-weight : bold ; font-size : 16pt;}
		 	div.given-names            {font-style : italic;}
		 	div.intro                  {border-style : inset; margin : 5px;}
		 	div.introduction           {border-style : inset; margin : 5px;}
		 	div.journal-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.journal-title-group    {background : #ffeeee;}
		 	div.article-title          {font-weight : bold ; font-size : 18pt;}
		 	div.kwd                    {font-style : italic}
		 	div.meta-name              {font-weight : bold ; font-size : 16pt;}
		 	div.name                   {font-weight : bold;}
		 	div.alt-title              {font-style : italic; font-size : 12px;}
		 	
		 	div.sec                    {border : 2px; margin 5px; padding 2px;}
		 	div.title                  {font-family : courier; font-weight : bold;
		 	                            font-size : 16pt; margin : 5px;}
		 	
		 	div.materials_methods      {border-style : double; margin : 5px; }
		 	div.methods                {border-style : double; margin : 5px; }
		 	
		 	div.results                {border-style : solid; margin : 5px;}
		 	div.background             {border-style : dotted; margin : 5px;}
		 	
		 	div.discussion             {border-style : groove; margin : 5px;}
		 	div.conclusion             {border-style : ridge; margin : 5px;}
		 	div.conclusions             {border-style : ridge; margin : 5px;}
		 	div.supplementary-material {border-style : inset; margin : 5px;}
		 	div.abbreviations          {border-style : double; border-color : red; margin : 5px;}
		 	div.competinginterests     {border-style : double; border-color : blue; margin : 5px;}
		 	div.acknowledgements       {border-style : double; border-color : green; margin : 5px;}
		 	div.authors_contributions   {border-style : double; border-color : purple; margin : 5px;}
		 	
		 	div.publisher              {border-style : outset; margin : 5px;}
		 	div.fn-type-conflict       {background : #f88; }
		 	div.fn-type-con            {background : #ddf; }
		 	div.fn-type-other          {background : #ddd; }
		 	
		 	div.unknown                {background : #ffd;
									 	  border-style : solid;
									 	  border-width : 1px;
									 	  padding : 2 px;}
		 	  
      	    table                      {background : #ffffdd;}
		 	tr                         {background : #ddddff; padding : 1px;}
		 	
		 	span                       {background : #ffcccc;}
		 	
		 	span.citation-author       {font-family : helvetica; background : #ffeeee;}
		 	span.collab                {background : #ddffff; }
		 	span.comment               {font-family : courier; font-size : 6px; background : #ffaaff;}
		 	span.contrib               {background : #ffffff;}
		 	span.corresp               {background : #ddffdd; }
		 	span.doi                   {background : #ffffff;}
		 	span.email                 {font-family : courier; }
		 	span.etal                  {font-style : italic;}
		 	span.fpage                 {font-family : courier;}
		 	span.given-names           {background : #ffffff;}
		 	span.iso-abbrev            {background : #ffffff;}
		 	span.issn-epub             {background : #ffffff;}
		 	span.issn-ppub             {background : #ffffff;}
		 	span.journal-title         {background : #ffffff;}
		 	span.lpage                 {font-family : courier;}
		 	span.mixed-article-title   {font-style : italic ;}
		 	span.nlm-ta                {background : #ffffff;}
		 	span.pmc                   {background : #ffffff;}
		 	span.pmcid                 {background : #ffffff;}
		 	span.pmid                  {background : #ffffff;}
		 	span.publisher             {background : #ffffff;}
		 	span.publisher-id          {background : #ffffff;}
		 	span.publisher-name        {background : #ffffff;}
		 	span.source                {background : #ffffff;}
		 	span.subject               {background : #ffffff;}
		 	span.surname               {background : #ffffff;}
		 	span.volume                {font-family : courier; font-weight : bold;}
		 	span.year                  {font-family : courier ; font-style : italic;}
			</style> </head> <body> <div class="front" title="front"> <div class="journal-meta" tagx="journal-meta" title="journal-meta"><span class="nlm-ta" title="nlm-ta">J Biomol Struct Dyn</span><span class="iso-abbrev" title="iso-abbrev">J. Biomol. Struct. Dyn</span><div class="journal-title-group" tagx="journal-title-group" title="journal-title-group"><span class="journal-title" tagx="journal-title" title="journal-title">Journal of Biomolecular Structure &amp;amp; Dynamics</span></div><span class="issn-ppub" tagx="issn" title="issn-ppub">0739-1102</span><span class="issn-epub" tagx="issn" title="issn-epub">1538-0254</span><div class="publisher" tagx="publisher" title="publisher"><span class="publisher-name" tagx="publisher-name" title="publisher-name">Taylor &amp;amp; Francis</span></div> </div> <div class="article-meta" tagx="article-meta" title="article-meta"><span class="pmcid" title="pmcid"> pmcid: <a href="http://www.ncbi.nlm.nih.gov/pubmed/7441781">7441781</a></span><span class="doi" title="doi"> doi: <a href="https://dx.doi.org/10.1080/07391102.2020.1798285">10.1080/07391102.2020.1798285</a></span><span class="publisher-id" title="publisher-id">1798285</span><div class="unknown" title="article-version" tag="article-version">
Version of Record</div> <div class="article-categories" title="article-categories">
: <span class="subject" title="subject">Research Article</span>: <span class="subject" title="subject">Research Article</span></div> <div class="title-group" tagx="title-group" title="title-group"> <div class="article-title" title="article-title">
Identification of some novel oxazine substituted 9-anilinoacridines as SARS-CoV-2 inhibitors for COVID-19 by molecular docking, free energy calculation and molecular dynamics studies</div> <div class="alt-title" title="alt-title">
K. Rajagopal et al.</div> <div class="alt-title" title="alt-title">
Journal of Biomolecular Structure and Dynamics</div> </div> <div class="contrib-group" title="contrib-group"><span class="contrib" title="contrib"><span class="contrib-id" tagx="contrib-id" title="contrib-id">https://orcid.org/0000-0003-3382-4316</span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rajagopal</span><span class="given-names" tagx="given-names" title="given-names">Kalirajan</span></span><a href="#AN0001" /><a href="#AF0001" /></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Varakumar</span><span class="given-names" tagx="given-names" title="given-names">Potlapati</span></span><a href="#AF0001" /></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Aparna</span><span class="given-names" tagx="given-names" title="given-names">Baliwada</span></span><a href="#AF0001" /></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Byran</span><span class="given-names" tagx="given-names" title="given-names">Gowramma</span></span><a href="#AF0001" /></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jupudi</span><span class="given-names" tagx="given-names" title="given-names">Srikanth</span></span><a href="#AF0001" /></span><span class="citation_author_institution" id="AF0001">[], <span class="institution" title="institution">Department of Pharmaceutical Chemistry, JSS College of Pharmacy [A Constituent College of JSS Academy of Higher Education &amp;amp; Research-(Deemed to be University)]</span><span class="city" tagx="city" title="city">Ooty</span><span class="state" tagx="state" title="state">Tamilnadu</span><span class="country" tagx="country" title="country">India</span></span></div> <div class="author-notes" title="author-notes"> <div class="corresp" title="corresp"><b>CONTACT</b> Kalirajan Rajagopal <span class="email" tagx="email" title="email">rkalirajan@ymail.com</span>; <span class="email" tagx="email" title="email">rkalirajan@jssuni.edu.in</span><span class="institution" title="institution">Department of Pharmaceutical Chemistry, JSS College of Pharmacy [A Constituent college of JSS Academy of Higher Education &amp;amp; Research-(Deemed to be University)]</span>, <span class="city" tagx="city" title="city">Ooty</span>, <span class="state" tagx="state" title="state">Tamilnadu</span><span class="postal-code" tagx="postal-code" title="postal-code">643001</span>, <span class="country" tagx="country" title="country">India</span>.</div> <div class="fn-type-" title=""> <p>Supplemental data for this article can be accessed online at <a href="https://doi.org/10.1080/07391102.2020.1798285">https://doi.org/10.1080/07391102.2020.1798285</a>.</p> </div> </div><span class="pub-date-" title="pub-date-">: <span>2020-7-7</span></span><span class="pub-date-" title="pub-date-">: <span>2020</span></span><span class="fpage" tagx="fpage" title="fpage">1</span><span class="lpage" tagx="lpage" title="lpage">12</span><div class="permissions"><span class="copyright" title="copyright">(C) <span class="copyright-holder" tagx="copyright-holder" title="copyright-holder">Informa UK Limited, trading as Taylor &amp;amp; Francis Group</span>, <span class="copyright-year" tagx="copyright-year" title="copyright-year">2020</span></span><span class="license" title="license"><span class="license-p" title="license-p">This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.</span></span></div><a class="self-uri" href="TBSD_0_1798285.pdf" title="self-uri">TBSD_0_1798285.pdf</a><div class="abstract" title="abstract"> <div class="abstract-title" title="abstract-title">
Abstract</div> <div class="title" tagx="title" title="title">
Abstract</div> <p>Coronavirus disease (COVID-19), a life-threatening disease, is caused by SARS-CoV-2. The targeted therapeutics of small molecules helps the scientific community to fight against SARS-CoV-2. In this article, some oxazine substituted 9-anilinoacridines (<b>A1â€"A48</b>) was designed by docking, MM-GBSA and molecular dynamics (MD) simulation studies for their COVID-19 inhibitory activity. The docking of ligands <b>A1â€"A48</b> against SARS-CoV-2 (PDB ID: 5R82) are performed by using Glide module, <i>in silico</i> ADMET screening by QikProp module, binding energy using Prime MM-GB/SA module, MD simulation by Desmond module and atomic charges were derived by Jaguar module of Schrodinger suit 2019-4. Compound <b>A38</b> has the highest G-score (âˆ’7.83) when compared to all the standard compounds which are proposed for COVID-19 treatment such as ritonavir (âˆ’7.48), lopinavir (âˆ’6.94), nelfinavir (âˆ’5.93), hydroxychloroquine (âˆ’5.47) and mataquine (âˆ’5.37). Compounds <b>A13</b>, <b>A23</b>, <b>A18</b>, <b>A7</b>, <b>A48</b>, <b>A46</b>, <b>A32</b>, <b>A20</b>, <b>A1</b> and <b>A47</b> are significantly active against SARS-CoV-2 main protease when compared with hydroxychloroquine and mataquine. The residues GLN19, THR24, THR25, THR26, LEU27, HIE41, SER46, MET49, ASN119, ASN142, HIE164, MET165, ASP187, ARG188 and GLN189 of SARS-CoV-2 main protease play a crucial role in binding with ligands. The <i>in silico</i> ADMET properties of the molecules are within the recommended values. The binding free energy was calculated using PRIME MM-GB/SA studies. From the ligands <b>A38</b>, <b>A13</b>, <b>A23</b>, <b>A18</b>, <b>A7</b>, <b>A48</b> and <b>A46</b> with significant Glide scores may produce significant COVID-19 activity for further development. Compound <b>A38</b> was subjected to MD simulation at 100â€‰ns to study the dynamic behaviour of proteinâ€"ligand complex.</p> <p>Communicated by Ramaswamy H. Sarma</p> </div> <div class="kwd-group"> <div class="title" tagx="title" title="title">
Keywords</div> <div class="kwd" title="kwd">
SARS-CoV-2</div> <div class="kwd" title="kwd">
COVID-19</div> <div class="kwd" title="kwd">
acridine</div> <div class="kwd" title="kwd">
oxazine</div> <div class="kwd" title="kwd">
docking studies</div> <div class="kwd" title="kwd"><i>in silico</i> ADMET screening</div> <div class="kwd" title="kwd">
MM-GBSA</div> <div class="kwd" title="kwd">
molecular dynamics simulation</div> </div> <div class="counts" title="counts"><span class="fig-count" title="fig-count">fig-count: </span><span class="table-count" title="table-count">table-count: </span><span class="page-count" title="page-count">page-count: </span><span class="word-count" title="word-count">word-count: </span></div> </div> </div> <div class="body" title="body"> <div class="introduction" title="sec"><span class="label" tagx="label" title="label">1.</span><div class="title" tagx="title" title="title">
Introduction</div> <p>Recently, coronavirus disease 2019 (COVID-19), a life-threatening disease, spreads throughout the world. The coronaviruses (CoVs) belong to severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS) viruses (De Wit etÂ al., <a href="#CIT0005">2016</a>; Song etÂ al., <a href="#CIT0044">2019</a>), which contain single positive-stranded RNA. It was affected first in China and quickly spread in most of the countries (Holshue etÂ al., <a href="#CIT0013">2020</a>; Wang etÂ al., <a href="#CIT0047">2020</a>; Zhou, Hou, etÂ al., <a href="#CIT0049">2020</a>). According to the WHO data, as on third week of May 2020, more than 5 million people in the world are affected by COVID-19; out of these, more than 3.3 lakh people are died. Many of the cases affected by COVID 19 are found to be asymptomatic (Gu etÂ al., <a href="#CIT0011">2020</a>; Holshue etÂ al., <a href="#CIT0013">2020</a>; Lu etÂ al., <a href="#CIT0034">2020</a>; To etÂ al., <a href="#CIT0045">2020</a>), it is worthy of consideration, the detail current evidence and understanding of the transmission of SARS-CoV, MERS-CoV and SARS-CoV-2 and discuss pathogen inactivation methods on CoVs is very important (Chang etÂ al., <a href="#CIT0004">2020</a>; Huang etÂ al., <a href="#CIT0014">2020</a>; Huang &amp;amp; Herrmann, <a href="#CIT0015">2020</a>; Zhang etÂ al., <a href="#CIT0048">2020</a>; Zhou, Yang, etÂ al., <a href="#CIT0050">2020</a>).</p> <p>The CoV transfers from human to human and spreads more vigorously. In this pathetic situation, it is important to discover some novel drugs to treat COVID-19. As COVID-19-positive cases are increased day by day more aggressively, the finding of novel drugs for COVID-19 treatments is one of the most encouraging tasks for target-based treatment.</p> <p>As a part of our ongoing research on searching the potent biological molecules against various diseases by <i>in silico</i> and wet laboratory methods (Kalirajan etÂ al., <a href="#CIT0027">2011</a>; Kalirajan, Kulshrestha, etÂ al., <a href="#CIT0021">2012</a>; Kalirajan, Mohammed Rafick, etÂ al., <a href="#CIT0022">2012</a>; Kalirajan etÂ al., <a href="#CIT0025">2013</a>; Kalirajan, Gowramma, etÂ al., <a href="#CIT0019">2017</a>; Kalirajan, Sankar, etÂ al., <a href="#CIT0028">2017</a>; Kalirajan, Kulshrestha, etÂ al., <a href="#CIT0020">2018</a>; Kalirajan, Mohammed Rafick, etÂ al., <a href="#CIT0023">2018</a>; Kalirajan, Gaurav, etÂ al., <a href="#CIT0018">2019</a>; Kalirajan, Pandiselvi, etÂ al., <a href="#CIT0026">2019</a>), we have designed and evaluated various heterocyclic compounds for their biological activities. Using different modules (Glide, QikProp, Prime and Desmond) of SchrÃ¶dinger suite LLC, various computational methods such as molecular docking, ADMET screening, binding free energy calculations and molecular dynamics (MD) simulations were performed to find the interactions responsible for COVID-19 inhibition. These studies will provide the requirement of key structural features in the design of potential drug candidates.</p> <p>It is evident that from the literature studies, 9-anilinoacridines have various pharmacological activities such as anticancer (Kapuriya etÂ al., <a href="#CIT0031">2008</a>; ; Wakelin etÂ al., <a href="#CIT0046">2003</a>), antimicrobial (Nadaraj etÂ al., <a href="#CIT0037">2009</a>), antioxidant (Dickens etÂ al., <a href="#CIT0006">2002</a>), antimalarial (Anderson etÂ al., <a href="#CIT0001">2006</a>), analgesic (Sondhi etÂ al., <a href="#CIT0043">2002</a>), antileishmanial (Giorgio etÂ al., <a href="#CIT0008">2007</a>), antinociceptive (Llama etÂ al., <a href="#CIT0033">1989</a>), acetyl cholinesterase inhibitors (Recanatini etÂ al., <a href="#CIT0041">2000</a>), antiherpes (Goodell etÂ al., <a href="#CIT0009">2006</a>) and so forth. Amsacrine that is 9-anilinoacridine derivative was a primary DNA-intercalating agent which is more significant and the chromophore intercalates with DNA base pairs (Rastogi etÂ al., <a href="#CIT0040">2002</a>). Similarly, oxazine derivatives were also reported for various biological activities (Kalirajan etÂ al., <a href="#CIT0029">2009</a>; Kalirajan, Muralidharan, etÂ al., <a href="#CIT0024">2012</a>) such as antimicrobial, anti-cancer, and larvicidal. As a part of our ongoing research work, upon looking for various biological activities, we have designed 9-anilinoacridine analogues bearing the oxazine build-up by docking studies with Schrodinger suit-2019-4. The recently designed 9-anilinoacridines showed significant hindrance with COVID-19.</p> </div> <div class="materialsandmethods" title="sec"><span class="label" tagx="label" title="label">2.</span><div class="title" tagx="title" title="title">
Materials and methods</div> <div class="moleculardockingstudies" title="sec"><span class="label" tagx="label" title="label">2.1.</span><div class="title" tagx="title" title="title">
Molecular docking studies</div> <p>The 3D crystal structure of COVID-19 protein called SARS-CoV-2 main protease receptor co-crystallized with 6-(ethylamino) pyridine-3-carbonitrile (PDB ID: 5R82, Resolution: 1.31â€‰Ã…) was retrieved from the protein data bank. The protein was prepared using protein preparation wizard of epic module (Sastry etÂ al., <a href="#CIT0042">2013</a>) of SchrÃ¶dinger suite 2019. The protein structure is a monomer, which was prepared by removing similar binding sites, unnecessary water molecules and also refining bond orders. Missing chain atoms are added by using the prime module of SchrÃ¶dinger suite 2019. Protein minimization was performed using optimized potentials for liquid simulations-3 (OPLS-3) molecular force field with root mean square difference (RMSD) of crystallographic heavy atoms kept at 0.3â€‰Ã…. A grid box was generated to define the centroid of the active site.</p> <p>The designed ligands (<b>A1â€"A48</b>) were prepared by using LigPrep module of Schrodinger suite 2019-4. 2D structures were converted to 3D structures, as well as energy minimization and optimized for their geometry, desalted and corrected for their chirality. The ionization and tautomeric states were generated between pH 6.8 and 7.2 by using Epik module. The ligands <b>A1â€"A48</b> were minimized using OPLS-3 force field in Schrodinger suit 2019-4 until a RMSD of 2.0â€‰Ã… was achieved. A single low energy ring confirmation per ligand was generated, and the optimized ligands were used for docking analysis.</p> <p>The compounds are prepared by LigPrep module of SchrÃ¶dinger suite and docked in to a catalytic pocket of COVID-19 by using Glide module of SchrÃ¶dinger suite 2019 in XP (extra precision) mode (Jacobson etÂ al., <a href="#CIT0016">2004</a>). The binding modes with best glide G scores were selected. These scores perceive positive lipophilic, hydrogen-bonding and metalâ€"ligand associations and punish steric conflicts. The XP visualizer of Glide module was used to analyze the results of docking studies (Friesner etÂ al., <a href="#CIT0007">2006</a>). The Glide score of the molecules was compared with the Glide score of the standard compounds ritonavir, lopinavir, nelfinavir, hydroxychloroquine and mataquine (Barros etÂ al., <a href="#CIT0002">2020</a>; Cao etÂ al., <a href="#CIT0003">2020</a>) which is recommended for COVID-19. The Gide scoring capacity is mainly dependent on docking parameters like lipophilic perseverance in which the ligands are covered in the lipophilic pocket. The electrostatic forces and hydrogen bonding with ligands are other parameters to increase the binding affinity. Some negative parameters like XP penalties, rotational penalties etc. will diminish the Glide score.</p> <p>The <i>in silico</i> ADMET properties of the proposed ligands <b>A1â€"A48</b> were determined by QikProp module of Schrodinger suit. The prepared ligands were subjected to the QikProp module to determine the ADMET properties such as molecular weight, dipole moment, number of H-bond donors and acceptors, log P values, violence in rule of five, and oral absorption.</p> <p>The atomic charges were derived using B3LYP hybrid functional combined with 6-31G basis set in Jaguar module of Schrodinger (Govindarajan etÂ al., <a href="#CIT0010">2012</a>).</p> </div> <div class="bindingfreeenergycalculationbyusingprime/mm-gbsaapproach" title="sec"><span class="label" tagx="label" title="label">2.2.</span><div class="title" tagx="title" title="title">
Binding free energy calculation by using prime/MM-GBSA approach</div> <p>The binding free energy of ligand-receptor complex and post docking energy minimization studies were performed using prime molecular mechanics-generalized born surface area (MM-GB/SA) of SchrÃ¶dinger 2019. The energy for minimized XP docked pose of ligand receptor complex was calculated using the OPLS3 force field and generalized-born/surface area (GB/SA) continuum VSGB 2.0 solvent model (Li etÂ al., <a href="#CIT0032">2011</a>).</p> </div> <div class="mdsimulation" title="sec"><span class="label" tagx="label" title="label">2.3.</span><div class="title" tagx="title" title="title">
MD simulation</div> <p>The stability of the docked <b>A38/5R82</b> complex was investigated by performing a 100â€‰ns MD (Guo etÂ al., <a href="#CIT0012">2010</a>) simulation study. The complex in the explicit solvent system with OPLS3 force field was studied using Desmond module of SchrÃ¶dinger 2019-4. The molecular system was solvated with crystallographic water (TIP3P) molecules (Jorgensen etÂ al., <a href="#CIT0017">1983</a>) under orthorhombic periodic boundary conditions for 10â€‰Ã… buffer region. The overlapping water molecules are deleted, and the system was neutralized by adding Na<sup>+</sup> as counter ions. The total system consists of 39,270 atoms and 11,507 water molecules. An ensemble (NPT) of Nose-Hoover thermostat (Martyna etÂ al., <a href="#CIT0035">1992</a>, <a href="#CIT0036">1994</a>) and barostat was applied to maintain the constant temperature (300â€‰K) and pressure (1â€‰bar) of the systems, respectively. A hybrid energy minimization algorithm with 1000 steps of steepest descent followed by conjugate gradient algorithms was utilized. Another algorithm, limited memory Broyden-Fletcher-Goldfarb-Shanno (LBFGS) algorithm with convergence threshold gradient of 1â€‰kcal/mol/Ã… was also employed for energy minimization. A Smooth Particle Mesh Ewald method for calculating long range electrostatic interactions with a cut-off radius of 9â€‰Ã… for short range van der Waals and Coulomb interactions was used. Multiple time step RESPA integration (reference system propagator algorithms) was used in the dynamics study for bonded, near and far-bonded interactions with 2, 2 and 6 fs, respectively. The data were collected for every 100â€‰ps, and the obtained trajectory was analyzed with Maestro graphical interphase.</p> </div> </div> <div class="resultsanddiscussion" title="sec"><span class="label" tagx="label" title="label">3.</span><div class="title" tagx="title" title="title">
Results and discussion</div> <p>The results are summarized in <a href="#t0001">Tables 1â€"3</a> and <a href="#F0001 F0002 F0003 F0004 F0005 F0006">Figures 1â€"6</a>. The results revealed that the COVID-19 inhibitory property of the compounds <b>A1â€"A48</b> greatly depended on the chemical nature of the substituents. The chemical structures of oxazine substituted 9-anilinoacridines are given in <a href="#F0001">Figure 1</a>.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 1.</span></a></div>   <p>Structures of compounds <b>A1</b>â€"<b>A48</b>.</p>   </div> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 2.</span></a></div>   <p>(a) Ligand Interaction of compound <b>A38</b> with COVID-19 (5R82). (b). Ligand Interaction of compound <b>A13</b> with COVID-19 (5R82). (c) Ligand Interaction of compound <b>A23</b> with COVID-19 (5R82). (d) Ligand Interaction of compound <b>A18</b> with COVID-19 (5R82). (e) Ligand Interaction of compound <b>A7</b> with COVID-19 (5R82). (f) Ligand Interaction of compound <b>A48</b> with COVID-19 (5R82). (g) Ligand Interaction of compound <b>A46</b> with COVID-19 (5R82). (h) Ligand Interaction of compound <b>A32</b> with COVID-19 (5R82).</p>   </div> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 3.</span></a></div>   <p>Hydrogen bonding interaction of compound <b>A13</b> with COVID-19 (5R82).</p>   </div> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 4.</span></a></div>   <p>Hydrophilic/lipophilic map of compound <b>A23</b> with COVID-19 (5R82).</p>   </div> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 5.</span></a></div>   <p>RMSD (Ã…) of simulated protein 5R82.<i>pdb</i> in complex with inhibitor <b>A38</b> during 100â€‰ns MD simulation.</p>   </div> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 6.</span></a></div>   <p>RMSF of simulated protein 5R82.<i>pdb</i> in complex with inhibitor <b>A38</b> during 100â€‰ns MD simulation.</p>   </div> <div class="table-wrap_UNKNOWN" id="t0001" orientation="portrait" position="float"><span class="label" tagx="label" title="label">Table 1.</span> <p>Docking studies for oxazine substituted 9-anilinoacridines <b>A1â€"A48</b> with COVID-19 (5R82).</p>  <table frame="hsides" rules="groups"> <colgroup> <col width="1*" /></colgroup> <colgroup><col width="1*" /></colgroup> <colgroup><col width="1*" /></colgroup> <colgroup><col width="1*" /></colgroup> <colgroup><col width="1*" /></colgroup> <colgroup><col width="1*" /></colgroup> <colgroup><col width="1*" /></colgroup> <colgroup><col width="1*" /></colgroup>  <thead> <tr> <th align="left">Cpd</th> <th align="center">Glide score</th> <th align="center">Lipophilic EvdW</th> <th align="center">H Bond</th> <th align="center">XP Electro</th> <th align="center">Low MW</th> <th align="center">XP Penalties</th> <th align="center">Rot Penal</th> </tr> </thead> <tbody valign="top"> <tr> <td align="left">A38</td> <td align="char" char=".">âˆ’7.829</td> <td align="char" char=".">âˆ’5.174</td> <td align="center">âˆ’1.081</td> <td align="char" char=".">âˆ’1.98</td> <td align="center">0</td> <td align="center">0</td> <td align="char" char=".">0.146</td> </tr> <tr> <td align="left">A13</td> <td align="char" char=".">âˆ’6.78</td> <td align="char" char=".">âˆ’5.77</td> <td align="center">âˆ’1.48</td> <td align="char" char=".">âˆ’0.57</td> <td align="center">0</td> <td align="center">0</td> <td align="char" char=".">0.16</td> </tr> <tr> <td align="left">A23</td> <td align="char" char=".">âˆ’6.65</td> <td align="char" char=".">âˆ’6.14</td> <td align="center">âˆ’0.61</td> <td align="char" char=".">âˆ’0.29</td> <td align="center">0</td> <td align="center">0</td> <td align="char" char=".">0.14</td> </tr> <tr> <td align="left">A18</td> <td align="char" char=".">âˆ’6.37</td> <td align="char" char=".">âˆ’5.75</td> <td align="center">âˆ’1</td> <td align="char" char=".">âˆ’0.36</td> <td align="center">0</td> <td align="center">0</td> <td align="char" char=".">0.15</td> </tr> <tr> <td align="left">A7</td> <td align="char" char=".">âˆ’6.12</td> <td align="char" char=".">âˆ’5.83</td> <td align="center">âˆ’1.04</td> <td align="char" char=".">âˆ’0.41</td> <td align="center">0</td> <td align="center">0</td> <td align="char" char=".">0.16</td> </tr> <tr> <td align="left">A48</td> <td align="char" char=".">âˆ’5.991</td> <td align="char" char=".">âˆ’5.129</td> <td align="center">âˆ’0.882</td> <td align="char" char=".">âˆ’0.195</td> <td align="center">âˆ’0.138</td> <td align="center">0</td> <td align="char" char=".">0.202</td> </tr> <tr> <td align="left">A46</td> <td align="char" char=".">âˆ’5.978</td> <td align="char" char=".">âˆ’5.145</td> <td align="center">âˆ’1.007</td> <td align="char" char=".">âˆ’0.248</td> <td align="center">âˆ’0.232</td> <td align="center">0</td> <td align="char" char=".">0.172</td> </tr> <tr> <td align="left">A32</td> <td align="char" char=".">âˆ’5.805</td> <td align="char" char=".">âˆ’5.499</td> <td align="center">âˆ’1.218</td> <td align="char" char=".">âˆ’0.289</td> <td align="center">0</td> <td align="center">0</td> <td align="char" char=".">0.164</td> </tr> <tr> <td align="left">A20</td> <td align="char" char=".">âˆ’5.80</td> <td align="char" char=".">âˆ’5.27</td> <td align="center">âˆ’1.28</td> <td align="char" char=".">âˆ’0.35</td> <td align="center">0</td> <td align="center">0</td> <td align="char" char=".">0.12</td> </tr> <tr> <td align="left">A1</td> <td align="char" char=".">âˆ’5.79</td> <td align="char" char=".">âˆ’5.77</td> <td align="center">âˆ’0.1</td> <td align="char" char=".">âˆ’0.11</td> <td align="center">0</td> <td align="center">0</td> <td align="char" char=".">0.13</td> </tr> <tr> <td align="left">A47</td> <td align="char" char=".">âˆ’5.784</td> <td align="char" char=".">âˆ’5.096</td> <td align="center">âˆ’0.454</td> <td align="char" char=".">âˆ’0.239</td> <td align="center">âˆ’0.185</td> <td align="center">0</td> <td align="char" char=".">0.161</td> </tr> <tr> <td align="left">A36</td> <td align="char" char=".">âˆ’5.478</td> <td align="char" char=".">âˆ’5.628</td> <td align="center">âˆ’0.649</td> <td align="char" char=".">âˆ’0.398</td> <td align="center">âˆ’0.005</td> <td align="center">1</td> <td align="char" char=".">0.171</td> </tr> <tr> <td align="left">A5</td> <td align="char" char=".">âˆ’5.34</td> <td align="char" char=".">âˆ’4.85</td> <td align="center">âˆ’0.89</td> <td align="char" char=".">âˆ’0.31</td> <td align="center">0</td> <td align="center">0</td> <td align="char" char=".">0.17</td> </tr> <tr> <td align="left">A12</td> <td align="char" char=".">âˆ’5.33</td> <td align="char" char=".">âˆ’5.02</td> <td align="center">âˆ’0.7</td> <td align="char" char=".">âˆ’0.5</td> <td align="center">0</td> <td align="center">0</td> <td align="char" char=".">0.15</td> </tr> <tr> <td align="left">A19</td> <td align="char" char=".">âˆ’5.22</td> <td align="char" char=".">âˆ’5.24</td> <td align="center">âˆ’0.53</td> <td align="char" char=".">âˆ’0.04</td> <td align="center">0</td> <td align="center">0</td> <td align="char" char=".">0.15</td> </tr> <tr> <td align="left">A25</td> <td align="char" char=".">âˆ’5.15</td> <td align="char" char=".">âˆ’5.33</td> <td align="center">âˆ’0.64</td> <td align="char" char=".">âˆ’0.29</td> <td align="center">0</td> <td align="center">0</td> <td align="char" char=".">0.14</td> </tr> <tr> <td align="left">A11</td> <td align="char" char=".">âˆ’5.05</td> <td align="char" char=".">âˆ’5.36</td> <td align="center">âˆ’0.7</td> <td align="char" char=".">âˆ’0.32</td> <td align="center">0</td> <td align="center">0</td> <td align="char" char=".">0.16</td> </tr> <tr> <td align="left">A45</td> <td align="char" char=".">âˆ’4.99</td> <td align="char" char=".">âˆ’5.261</td> <td align="center">âˆ’0.53</td> <td align="char" char=".">âˆ’0.176</td> <td align="center">âˆ’0.022</td> <td align="center">0</td> <td align="char" char=".">0.174</td> </tr> <tr> <td align="left">A8</td> <td align="char" char=".">âˆ’4.82</td> <td align="char" char=".">âˆ’5.42</td> <td align="center">âˆ’0.35</td> <td align="char" char=".">âˆ’0.05</td> <td align="center">0</td> <td align="center">0</td> <td align="char" char=".">0.16</td> </tr> <tr> <td align="left">A35</td> <td align="char" char=".">âˆ’4.80</td> <td align="char" char=".">âˆ’5.316</td> <td align="center">âˆ’0.171</td> <td align="char" char=".">âˆ’0.132</td> <td align="center">0</td> <td align="center">0</td> <td align="char" char=".">0.147</td> </tr> <tr> <td align="left">A9</td> <td align="char" char=".">âˆ’4.72</td> <td align="char" char=".">âˆ’5.46</td> <td align="center">âˆ’0.21</td> <td align="char" char=".">âˆ’0.05</td> <td align="center">0</td> <td align="center">0</td> <td align="char" char=".">0.16</td> </tr> <tr> <td align="left">A22</td> <td align="char" char=".">âˆ’4.56</td> <td align="char" char=".">âˆ’5.38</td> <td align="center">âˆ’0.04</td> <td align="char" char=".">âˆ’0.06</td> <td align="center">0</td> <td align="center">0</td> <td align="char" char=".">0.12</td> </tr> <tr> <td align="left">A40</td> <td align="char" char=".">âˆ’4.50</td> <td align="char" char=".">âˆ’5.217</td> <td align="center">âˆ’0.036</td> <td align="char" char=".">âˆ’0.093</td> <td align="center">0</td> <td align="center">0</td> <td align="char" char=".">0.134</td> </tr> <tr> <td align="left">A30</td> <td align="char" char=".">âˆ’4.48</td> <td align="char" char=".">âˆ’5.42</td> <td align="center">âˆ’0.082</td> <td align="char" char=".">âˆ’0.065</td> <td align="center">0</td> <td align="center">0</td> <td align="char" char=".">0.153</td> </tr> <tr> <td align="left">A31</td> <td align="char" char=".">âˆ’4.44</td> <td align="char" char=".">âˆ’5.683</td> <td align="center">âˆ’0.83</td> <td align="char" char=".">âˆ’0.292</td> <td align="center">0</td> <td align="center">1</td> <td align="char" char=".">0.153</td> </tr> <tr> <td align="left">A2</td> <td align="char" char=".">âˆ’4.40</td> <td align="char" char=".">âˆ’5.38</td> <td align="center">âˆ’0.08</td> <td align="char" char=".">âˆ’0.04</td> <td align="center">0</td> <td align="center">0</td> <td align="char" char=".">0.13</td> </tr> <tr> <td align="left">A16</td> <td align="char" char=".">âˆ’4.38</td> <td align="char" char=".">âˆ’5.24</td> <td align="center">âˆ’0.08</td> <td align="char" char=".">0.01</td> <td align="center">0</td> <td align="center">0</td> <td align="char" char=".">0.18</td> </tr> <tr> <td align="left">A17</td> <td align="char" char=".">âˆ’4.34</td> <td align="char" char=".">âˆ’5.14</td> <td align="center">âˆ’0.19</td> <td align="char" char=".">âˆ’0.06</td> <td align="center">0</td> <td align="center">0</td> <td align="char" char=".">0.13</td> </tr> <tr> <td align="left">A34</td> <td align="char" char=".">âˆ’4.321</td> <td align="char" char=".">âˆ’5.231</td> <td align="center">0</td> <td align="char" char=".">âˆ’0.039</td> <td align="center">0</td> <td align="center">0</td> <td align="char" char=".">0.147</td> </tr> <tr> <td align="left">A4</td> <td align="char" char=".">âˆ’4.23</td> <td align="char" char=".">âˆ’5.22</td> <td align="center">âˆ’0.12</td> <td align="char" char=".">âˆ’0.05</td> <td align="center">0</td> <td align="center">0</td> <td align="char" char=".">0.17</td> </tr> <tr> <td align="left">A21</td> <td align="char" char=".">âˆ’4.22</td> <td align="char" char=".">âˆ’5.06</td> <td align="center">0</td> <td align="char" char=".">âˆ’0.08</td> <td align="center">0</td> <td align="center">0</td> <td align="char" char=".">0.12</td> </tr> <tr> <td align="left">A15</td> <td align="char" char=".">âˆ’4.22</td> <td align="char" char=".">âˆ’5.32</td> <td align="center">0</td> <td align="char" char=".">0.01</td> <td align="center">0</td> <td align="center">0</td> <td align="char" char=".">0.18</td> </tr> <tr> <td align="left">A29</td> <td align="char" char=".">âˆ’4.202</td> <td align="char" char=".">âˆ’5.202</td> <td align="center">0</td> <td align="char" char=".">âˆ’0.063</td> <td align="center">0</td> <td align="center">0</td> <td align="char" char=".">0.153</td> </tr> <tr> <td align="left">A6</td> <td align="char" char=".">âˆ’4.16</td> <td align="char" char=".">âˆ’5.33</td> <td align="center">âˆ’0.04</td> <td align="char" char=".">âˆ’0.01</td> <td align="center">0</td> <td align="center">0</td> <td align="char" char=".">0.17</td> </tr> <tr> <td align="left">A24</td> <td align="char" char=".">âˆ’4.04</td> <td align="char" char=".">âˆ’5.31</td> <td align="center">âˆ’0.55</td> <td align="char" char=".">âˆ’0.31</td> <td align="center">0</td> <td align="center">1</td> <td align="char" char=".">0.13</td> </tr> <tr> <td align="left">A37</td> <td align="char" char=".">âˆ’3.96</td> <td align="char" char=".">âˆ’5.211</td> <td align="center">âˆ’0.223</td> <td align="char" char=".">âˆ’0.285</td> <td align="center">âˆ’0.058</td> <td align="center">1</td> <td align="char" char=".">0.182</td> </tr> <tr> <td align="left">A10</td> <td align="char" char=".">âˆ’3.89</td> <td align="char" char=".">âˆ’4.92</td> <td align="center">0</td> <td align="char" char=".">0</td> <td align="center">0</td> <td align="center">0</td> <td align="char" char=".">0.16</td> </tr> <tr> <td align="left">A3</td> <td align="char" char=".">âˆ’3.86</td> <td align="char" char=".">âˆ’4.56</td> <td align="center">âˆ’0.7</td> <td align="char" char=".">âˆ’0.31</td> <td align="center">0</td> <td align="center">0</td> <td align="char" char=".">0.13</td> </tr> <tr> <td align="left">A14</td> <td align="char" char=".">âˆ’3.82</td> <td align="char" char=".">âˆ’3.94</td> <td align="center">âˆ’0.7</td> <td align="char" char=".">âˆ’0.45</td> <td align="center">0</td> <td align="center">0</td> <td align="char" char=".">0.16</td> </tr> <tr> <td align="left">A39</td> <td align="char" char=".">âˆ’3.80</td> <td align="char" char=".">âˆ’5.169</td> <td align="center">âˆ’0.024</td> <td align="char" char=".">âˆ’0.065</td> <td align="center">0</td> <td align="center">0</td> <td align="char" char=".">0.179</td> </tr> <tr> <td align="left">A26</td> <td align="char" char=".">âˆ’3.07</td> <td align="char" char=".">âˆ’2.29</td> <td align="center">âˆ’1.35</td> <td align="char" char=".">âˆ’0.16</td> <td align="center">0</td> <td align="center">0</td> <td align="char" char=".">0.12</td> </tr> <tr> <td align="left">A44</td> <td align="char" char=".">âˆ’3.04</td> <td align="char" char=".">âˆ’5.171</td> <td align="center">âˆ’0.072</td> <td align="char" char=".">âˆ’0.017</td> <td align="center">âˆ’0.022</td> <td align="center">0</td> <td align="char" char=".">0.174</td> </tr> <tr> <td align="left">A33</td> <td align="char" char=".">âˆ’2.98</td> <td align="char" char=".">âˆ’4.977</td> <td align="center">0</td> <td align="char" char=".">âˆ’0.068</td> <td align="center">0</td> <td align="center">0</td> <td align="char" char=".">0.164</td> </tr> <tr> <td align="left">A27</td> <td align="char" char=".">âˆ’2.92</td> <td align="char" char=".">âˆ’4.943</td> <td align="center">0</td> <td align="char" char=".">0.044</td> <td align="center">âˆ’0.025</td> <td align="center">0</td> <td align="char" char=".">0.175</td> </tr> <tr> <td align="left">A43</td> <td align="char" char=".">âˆ’2.86</td> <td align="char" char=".">âˆ’5.088</td> <td align="center">âˆ’1.048</td> <td align="char" char=".">0.039</td> <td align="center">âˆ’0.022</td> <td align="center">1</td> <td align="char" char=".">0.174</td> </tr> <tr> <td align="left">A28</td> <td align="char" char=".">âˆ’2.67</td> <td align="char" char=".">âˆ’4.414</td> <td align="center">0</td> <td align="char" char=".">âˆ’0.133</td> <td align="center">0</td> <td align="center">0</td> <td align="char" char=".">0.155</td> </tr> <tr> <td align="left">A41</td> <td align="char" char=".">âˆ’2.58</td> <td align="char" char=".">âˆ’3.308</td> <td align="center">âˆ’0.7</td> <td align="char" char=".">âˆ’0.278</td> <td align="center">0</td> <td align="center">1</td> <td align="char" char=".">0.139</td> </tr> <tr> <td align="left">A42</td> <td align="char" char=".">âˆ’2.23</td> <td align="char" char=".">âˆ’3.137</td> <td align="center">0</td> <td align="char" char=".">âˆ’0.14</td> <td align="center">0</td> <td align="center">0</td> <td align="char" char=".">0.139</td> </tr> <tr> <td align="left">Hydroxychloroquine (Std)</td> <td align="char" char=".">âˆ’5.47</td> <td align="char" char=".">âˆ’3.15</td> <td align="center">âˆ’1.75</td> <td align="char" char=".">âˆ’0.69</td> <td align="center">âˆ’0.38</td> <td align="center">0.5</td> <td align="char" char=".">0</td> </tr> <tr> <td align="left">Ritonavir (Std)</td> <td align="char" char=".">âˆ’7.48</td> <td align="char" char=".">âˆ’6.57</td> <td align="center">âˆ’1.7</td> <td align="char" char=".">âˆ’0.46</td> <td align="center">0</td> <td align="center">0</td> <td align="char" char=".">0.22</td> </tr> <tr> <td align="left">Lopinavir (Std)</td> <td align="char" char=".">âˆ’6.94</td> <td align="char" char=".">âˆ’6.01</td> <td align="center">âˆ’1.12</td> <td align="char" char=".">âˆ’0.26</td> <td align="center">0</td> <td align="center">0</td> <td align="char" char=".">0.24</td> </tr> <tr> <td align="left">Nelfinavir (Std)</td> <td align="char" char=".">âˆ’5.93</td> <td align="char" char=".">âˆ’4.86</td> <td align="center">âˆ’1.18</td> <td align="char" char=".">âˆ’0.49</td> <td align="center">0</td> <td align="center">0</td> <td align="char" char=".">0.24</td> </tr> <tr> <td align="left">Metaquine (Std)</td> <td align="char" char=".">âˆ’5.37</td> <td align="char" char=".">âˆ’5.3</td> <td align="center">âˆ’0.7</td> <td align="char" char=".">âˆ’0.38</td> <td align="center">âˆ’0.06</td> <td align="center">0</td> <td align="char" char=".">0.18</td> </tr> <tr> <td align="left">6-(ethylamino)pyridine-3-carbonitrile (Bound inhibitor)</td> <td align="char" char=".">âˆ’4.40</td> <td align="char" char=".">âˆ’2.9</td> <td align="center">âˆ’0.7</td> <td align="char" char=".">âˆ’0.19</td> <td align="center">âˆ’0.5</td> <td align="center">0</td> <td align="char" char=".">0.29</td> </tr> </tbody> </table> </div> <div class="moleculardockingstudies" title="sec"><span class="label" tagx="label" title="label">3.1.</span><div class="title" tagx="title" title="title">
Molecular docking studies</div> <p>The docking studies of the ligands to protein active sites were performed by an advanced molecular docking program Glide module of Schrodinger suite 2019 Maestro-12.2 version for determining the binding affinities of the compounds. The designed analogues were docked towards the COVID-19 (PDB ID: 5R82) in order to ascertain their inhibitory activity. The analogues show a best fit RMSD value of 0.2. As shown in <a href="#t0001">Table 1</a>, it is clearly demonstrated that Compound <b>A38</b> has the highest G-score (âˆ’7.83) when compared to all the standard compounds which are proposed for COVID-19 treatment such as ritonavir (âˆ’7.48), lopinavir (âˆ’6.94), nelfinavir (âˆ’5.93), hydroxychloroquine (âˆ’5.47) and mataquine (âˆ’5.37). Compounds <b>A38</b>, <b>A13</b>, <b>A23</b>, <b>A18</b>, <b>A7</b>, <b>A48</b>, <b>A46</b>, <b>A32</b>, <b>A20</b>, <b>A1</b>, <b>A47</b> and <b>A36</b> are significantly active against COVID-19 with Glide score more than âˆ’5.5 when compared to currently used drug hydroxychloroquine (âˆ’5.47) and mataquine (âˆ’5.37). The above compounds have good affinity to the receptor due to more lipophilic character and hydrogen bonding.</p> <p>The docking results of the compounds exhibited similar mode of interactions with COVID-19 and the binding pocket of the residues between GLN19 and GLN189. The results are summarized in <a href="#t0001">Table 1</a>. Almost all Compounds <b>A1â€"A48</b> with COVID-19 (PDB ID: 5R82) are docked in the same binding pocket. From <a href="#F0002">Figure 2a</a>, the amino acid residues GLN19, THR24, THR25, THR26, SER46, HIE41, ASN142, HIE164 and GLN189 are making polar region and the amino acids LEU27, MET49 and MET165 are making hydrophobic interaction with the ligand. The hydroxyl group of the phenyl ring is interacted by hydrogen bonding with ASN 119. The Glide scores are mainly increased due to the lipophilic evidence of the aromatic moieties. The 2D-ligand interaction diagram of compounds <b>A38</b>, <b>A13</b>, <b>A23</b>, <b>A18</b>, <b>A7</b>, <b>A48</b>, <b>A46</b> and <b>A32</b> with COVID-19 (PDB ID: 5R82) are given in <a href="#F0002">Figure 2(aâ€"h)</a>.</p> <p>From the obtained binding modes, it was illustrated that the ligands formed hydrophobic, hydrogen bonding and other interactions with different residues GLN19 to GLN189 surrounding the active pocket. Ligand A13 exhibited hydrogen bonding interaction with ASN142 (H-bond length: 3.06â€‰Ã…) and ASN119 (H-bond length: 1.79â€‰Ã…) residues and these are shown in <a href="#F0003">Figure 3</a>. The presence of aromatic features and different heterocyclic rings majorly contributed towards lipophilic factors (<a href="#F0004">Figure 4</a>).</p> <p>The ADMET properties for compounds <b>A1â€"A48</b> can be investigated by the <i>in silico</i> method by using QikProp module of SchrÃ¶dinger suite 2019-4. The molecular weight of the compounds is between 380 and 544â€‰g mol<sup>âˆ’1</sup>. The dipole moment of the compounds is between 1 and 5.7. The estimated number of hydrogen bond donors of the compounds is in the range of 3â€"4. The estimated number of hydrogen bond acceptors of the compounds is in the range of 4.5â€"6.75. The number of likely metabolites of the compounds is in the range of 2â€"6. The number of violations of Lipinskiâ€™s rule of five is 0â€"2. The percentage of human oral absorption for the compounds is between 70% and 100%; Therefore, almost all the ADMET properties of the compounds are within the recommended values. The results of the ADMET properties for compounds <b>A1â€"A48</b> are shown in Table S1 (<a href="https://doi.org/10.1080/07391102.2020.1798285">supplementary material</a>).</p> <p>The atomic charges were derived using B3LYP hybrid functional combined with 6-31G basis set in Jaguar module of Schrodinger. The HOMO, LUMO and molecular surface property (ESP mean) values are illustrated in Table S3 (<a href="https://doi.org/10.1080/07391102.2020.1798285">supplementary material</a>).</p> </div> <div class="bindingfreeenergycalculationbyusingprime/mm-gbsaapproach" title="sec"><span class="label" tagx="label" title="label">3.2.</span><div class="title" tagx="title" title="title">
Binding free energy calculation by using prime/MM-GBSA approach</div> <p>Molecular docking was additionally assessed with MM-GBSA free restricting vitality, which is identified with the post scoring approach for COVID-19 (PDB ID: 5R82) target and the values are shown in <a href="https://doi.org/10.1080/07391102.2020.1798285">Supplementary Table S2</a> (<a href="https://doi.org/10.1080/07391102.2020.1798285">supplementary material</a>). Prime MMGBSA DG bind, the binding free energy, is calculated with the equation: </p><div class="disp-formula" title="disp-formula"> <div class="alternatives" title="alternatives"> <div class="graphic" position="float" orientation="portrait" /><div class="math_UNKNOWN"> <div class="mrow_UNKNOWN"> <div class="mo_UNKNOWN">
Î"</div> <div class="mi_UNKNOWN">
G</div> <div class="mrow_UNKNOWN"> <div class="mo_UNKNOWN">
(</div> <div class="mrow_UNKNOWN"> <div class="mtext_UNKNOWN">
bind</div> </div> <div class="mo_UNKNOWN">
)</div> </div> <div class="mi_UNKNOWN">
Â </div> <div class="mo_UNKNOWN">
=</div> <div class="mi_UNKNOWN">
Â </div> <div class="mi_UNKNOWN">
E</div> <div class="mo_UNKNOWN">
_</div> <div class="mtext_UNKNOWN">
complex</div> <div class="mrow_UNKNOWN"> <div class="mo_UNKNOWN">
(</div> <div class="mrow_UNKNOWN"> <div class="mtext_UNKNOWN">
minimized</div> </div> <div class="mo_UNKNOWN">
)</div> </div> <div class="mi_UNKNOWN">
Â </div> <div class="mo_UNKNOWN">
âˆ’</div> <div class="mi_UNKNOWN">
Â </div> <div class="mrow_UNKNOWN"> <div class="mo_UNKNOWN">
(</div> <div class="mrow_UNKNOWN"> <div class="mi_UNKNOWN">
E</div> <div class="mo_UNKNOWN">
_</div> <div class="mtext_UNKNOWN">
ligand</div> <div class="mrow_UNKNOWN"> <div class="mo_UNKNOWN">
(</div> <div class="mrow_UNKNOWN"> <div class="mtext_UNKNOWN">
minimized</div> </div> <div class="mo_UNKNOWN">
)</div> </div> <div class="mi_UNKNOWN">
Â </div> <div class="mo_UNKNOWN">
+</div> <div class="mi_UNKNOWN">
Â </div> <div class="mi_UNKNOWN">
E</div> <div class="mo_UNKNOWN">
_</div> <div class="mtext_UNKNOWN">
receptor</div> <div class="mrow_UNKNOWN"> <div class="mo_UNKNOWN">
(</div> <div class="mrow_UNKNOWN"> <div class="mtext_UNKNOWN">
minimized</div> </div> <div class="mo_UNKNOWN">
)</div> </div> </div> <div class="mo_UNKNOWN">
)</div> </div> </div></div></div> </div> <p /> <p>From the results of MM-GB/SA studies, the Î"<i>G</i> bind values were observed in the range of âˆ’26.01 (cpdA35) to âˆ’63.24â€‰kcal/mol (cpdA14) for significantly active compounds and also dGvdw values, dG lipophilic values and the energies are positively contributing towards total binding energy. The stability of docking complex will be predicted by MMGBSA scoring function. The Glide score and MM-GBSA free energy are obtained by the docking of ligands into the coupling pocket, which are more stable.</p> </div> <div class="mdsimulation" title="sec"><span class="label" tagx="label" title="label">3.3.</span><div class="title" tagx="title" title="title">
MD simulation</div> <p>A 100-ns molecular dynamic simulation was performed to understand the molecular insights involved in binding of <b>A38</b> in the active pocket of 5R82. From the obtained trajectory analysis, the RMSD of protein CÎ±, backbone and heavy atoms was observed in the range of 1.25â€"2.1â€‰Ã… and 1.45â€"2.45â€‰Ã…, respectively (<a href="#F0005">Figure 5</a>). The CÎ± atoms fluctuated in the range of 1.25â€"2.1â€‰Ã… and finally stabilized after 80â€‰ns of simulation with a RMSD value of 1.5â€‰Ã…. Higher fluctuations (up to 2.1â€‰Ã…) in RMSD were observed at 39â€"42â€‰ns and 79â€‰ns. Over the course of simulation, stable hydrophobic interactions were observed with His41 and Met165. The flexibility of residues on ligand binding is analyzed using metrics of root mean square fluctuations (RMSFs) (<a href="#F0006">Figure 6</a>). High flexibility was observed with RMSF of Ser1 (CÎ±: 4.67â€‰Ã…; backbone: 4.77â€‰Ã…) and Val303 (CÎ±: 5.95â€‰Ã…; backbone: 6.02â€‰Ã…), whereas low RMSF was reported for residues Leu205 (CÎ±: 0.37â€‰Ã…; backbone: 0.38â€‰Ã…) and Thr175 (CÎ±: 0.43â€‰Ã…; backbone: 0.46â€‰Ã…). The stability of ligand with respect to protein was indicated using ligand RMSD where a moderate fluctuation of 1.72â€‰Ã… was observed (<a href="#F0006">Figure 6</a>).</p> <p>A total of 27 ligand contacts (<a href="#F0007">Figure 7</a>) were formed with amino acids of protein, from Gln19 to Met49, Asn119, Phe140 to Pro168 and Phe181 to Gln192. From <a href="#F0008">Figure 8</a>, it was stated that the ligand is stabilized by forming majority of hydrophobic interactions (5%â€"90% of simulation time) with residues His41, Met49, Cys145, Met165, Leu167, Pro168 and Phe181. It also formed hydrogen bonds with Gly19, Asn28, His41, Asn119, Asn142, Gly143, Ser144 and Gln189 over the course of 10%â€"65% of simulation trajectory. The timeline representation of protein-ligand contacts is outlined in <a href="#F0008">Figure 8</a>.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 7.</span></a></div>   <p>Interaction fraction of 5R82.<i>pdb</i> complexed with <b>A38</b> during 100â€‰ns MD simulation.</p>   </div> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 8.</span></a></div>   <p>Time line representation showing different contacts formed by <b>A38</b> in complex with 5R82.<i>pdb</i> during 100â€‰ns MD simulation.</p>   </div> <p>The 2D-trajectory interaction diagram (<a href="#F0009">Figure 9</a>) depicts that the hydrogen bond formed by the docking pose with Asn119 is preserved in the MD trajectory pose. The methoxy group in compound A38 donated one hydrogen bond to Asn119 with 24%, the nitrogen of acridine ring accepted one hydrogen bond with Arg188 and Ser144 through water molecule with 21% and 51% of total simulation time, respectively. The nitrogen of the oxazine ring accepted one hydrogen bond from Gly143 and the amino group accepted hydrogen bonds from Gly143 and Ser144 with 58% and 51%, respectively, of total simulation time. The pi-pi stacking of acridine with His41 was 67%. The RMSF (<a href="#F0010">Figure 10</a>) of ligand with respect to initial frame was observed in the range of 0.5â€"1.48â€‰Ã…. Other ligand properties (<a href="#F0010">Figure 10</a>) such as radius of gyration, molecular surface area, solvent accessible surface area and polar surface area of ligands were observed in the range of 5.85â€"6.07â€‰Ã…, 444.94â€"453.42 Ã…<sup>2</sup>, 228.75â€"453.338.82 Ã…<sup>2</sup> and 149.94â€"164.73 Ã…<sup>2</sup>, respectively.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 9.</span></a></div>   <p>2D interaction diagram of <b>A38</b> in complex with 5R82.<i>pdb</i> during 100â€‰ns MD simulation.</p>   </div> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 10.</span></a></div>   <p>Ligand properties of <b>A38</b> in complex with 5R82.<i>pdb</i> during 100â€‰ns MD simulation.</p>   </div> </div> </div> <div class="conclusion" title="sec"><span class="label" tagx="label" title="label">4.</span><div class="title" tagx="title" title="title">
Conclusion</div> <p>In conclusion, from the oxazine-substituted 9-anilinoacridines <b>A1â€"A48</b>, many compounds have significant binding affinity with SARS CoV-2 main protease. Molecular docking and binding free energy calculation studies were performed to find the possible binding modes of ligands and the influence of favorable and non-favourable interactions within the active pocket of COVID-19 protein. MD simulation for the highly active inhibitor <b>A38</b> in complex with protein 5R82 revealed that the stabilization of ligand was achieved due to the formation of uninterrupted hydrophobic interactions. The results demonstrated for further modifications in pharmacophoric features may help in improvement of inhibitory activity. The <i>in silico</i> structuring strategy embraced in the present investigation helped for recognizing some lead molecules and furthermore may somewhat clarify their useful impact for further determinations like <i>inÂ vitro</i> and <i>inÂ vivo</i> assessments. The results from the <i>in silico</i> study exhibited that compounds <b>A38</b>, <b>A13</b>, <b>A23</b>, <b>A18</b> and <b>A7</b> may be significantly active against COVID-19 with remedial possibilities and are probably going to be helpful after further refinement.</p> </div> <div class="supplementary-material" title="supplementary-material"> <div class="title" tagx="title" title="title">
Supplementary Material</div> <div class="local-data" title="local-data">  <div class="title" tagx="title" title="title">
Supplementary_materials...docx</div>  <div class="media" title="media"><a href="TBSD_A_1798285_SM7947.docx">LINK</a> <p>Click here for additional data file.</p>  </div> </div> </div> </div> <div class="back" title="back"> <div class="ack" title="ack"> <div class="title" tagx="title" title="title">
Acknowledgements</div> <p>The authors express their sincere gratitude to JSS Academy of Higher Education &amp;amp; Research, Mysuru. The authors also thank the principal Dr. S. P. Dhanabal, JSS College of Pharmacy, Ooty, for the technical support.</p> </div> <div class="COI-statement" title="COI-statement"> <div class="title" tagx="title" title="title">
Disclosure statement</div> <p>No potential conflict of interest was reported by the authors.</p> </div> <div class="references">
References</div> <div tag="ref-list"> <ul> <div class="title" tagx="title" title="title">
References</div> <li tag="ref"><a name="CIT0001" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Anderson</span><span class="given-names" tagx="given-names" title="given-names">M. O.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sherrill</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Madrid</span><span class="given-names" tagx="given-names" title="given-names">P. B.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liou</span><span class="given-names" tagx="given-names" title="given-names">A. P.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Weisman</span><span class="given-names" tagx="given-names" title="given-names">J. L.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">DeRisi</span><span class="given-names" tagx="given-names" title="given-names">J. L.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Guy</span><span class="given-names" tagx="given-names" title="given-names">R. K.</span></span></span> (<span class="year" tagx="year" title="year">2006</span>). <span class="mixed-article-title" title="mixed-article-title">Parallel synthesis of 9-aminoacridines and their evaluation against chloroquine-resistant Plasmodium falciparum</span>. <span class="source" tagx="source" title="source"><i>Bioorganic &amp;amp; Medicinal Chemistry</i></span>, (<span class="issue" tagx="issue" title="issue">2</span>), <span class="fpage" tagx="fpage" title="fpage">334</span>â€"<span class="lpage" tagx="lpage" title="lpage">343</span>. <span class="pub-id"><a href="https://dx.doi.org/10.1016/j.bmc.2005.08.017">10.1016/j.bmc.2005.08.017</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16216519">16216519</a></span></span></li> <li tag="ref"><a name="CIT0002" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Barros</span><span class="given-names" tagx="given-names" title="given-names">R. O.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Junior</span><span class="given-names" tagx="given-names" title="given-names">F. L. C. C.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pereira</span><span class="given-names" tagx="given-names" title="given-names">W. S.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Oliveira</span><span class="given-names" tagx="given-names" title="given-names">N. M. N.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ramos</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span></span> (<span class="year" tagx="year" title="year">2020</span>). <span class="mixed-article-title" title="mixed-article-title">Interaction of drugs candidates with various SARS-CoV-2 receptors: An in silico study to combat COVID-19</span>. <span class="source" tagx="source" title="source"><i>ChemRxiv</i></span>. Preprint. <span class="pub-id"><a href="https://dx.doi.org/10.26434/chemrxiv.12100968.v4">10.26434/chemrxiv.12100968.v4</a></span></span></li> <li tag="ref"><a name="CIT0003" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cao</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wen</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">W.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fan</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ruan</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Song</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cai</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wei</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xia</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">N.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xiang</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yu</span><span class="given-names" tagx="given-names" title="given-names">T.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bai</span><span class="given-names" tagx="given-names" title="given-names">T.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xie</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span>, â€¦ <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span></span> (<span class="year" tagx="year" title="year">2020</span>). <span class="mixed-article-title" title="mixed-article-title">A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19</span>. <span class="source" tagx="source" title="source"><i>The New England Journal of Medicine</i></span>, (<span class="issue" tagx="issue" title="issue">19</span>), <span class="fpage" tagx="fpage" title="fpage">1787</span>â€"<span class="lpage" tagx="lpage" title="lpage">1799</span>. <span class="pub-id"><a href="https://dx.doi.org/10.1056/NEJMoa2001282">10.1056/NEJMoa2001282</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32187464">32187464</a></span></span></li> <li tag="ref"><a name="CIT0004" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chang</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yan</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span></span> (<span class="year" tagx="year" title="year">2020</span>). <span class="mixed-article-title" title="mixed-article-title">Coronavirus disease 2019: Coronaviruses and blood safety</span>. <span class="source" tagx="source" title="source"><i>Transfusion Medicine Reviews</i></span>, (<span class="issue" tagx="issue" title="issue">2</span>), <span class="fpage" tagx="fpage" title="fpage">75</span>â€"<span class="lpage" tagx="lpage" title="lpage">80</span>. <span class="pub-id"><a href="https://dx.doi.org/10.1016/j.tmrv.2020.02.003">10.1016/j.tmrv.2020.02.003</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32107119">32107119</a></span></span></li> <li tag="ref"><a name="CIT0005" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">De Wit</span><span class="given-names" tagx="given-names" title="given-names">E.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Van Doremalen</span><span class="given-names" tagx="given-names" title="given-names">N.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Falzarano</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Munster</span><span class="given-names" tagx="given-names" title="given-names">V. J.</span></span></span> (<span class="year" tagx="year" title="year">2016</span>). <span class="mixed-article-title" title="mixed-article-title">SARS and MERS: Recent insights into emerging coronaviruses</span>. <span class="source" tagx="source" title="source"><i>Nature Reviews. Microbiology</i></span>, (<span class="issue" tagx="issue" title="issue">8</span>), <span class="fpage" tagx="fpage" title="fpage">523</span>â€"<span class="lpage" tagx="lpage" title="lpage">534</span>. <span class="pub-id"><a href="https://dx.doi.org/10.1038/nrmicro.2016.81">10.1038/nrmicro.2016.81</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27344959">27344959</a></span></span></li> <li tag="ref"><a name="CIT0006" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dickens</span><span class="given-names" tagx="given-names" title="given-names">B. F.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Weglicki</span><span class="given-names" tagx="given-names" title="given-names">W. B.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Boehme</span><span class="given-names" tagx="given-names" title="given-names">P. A.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mak</span><span class="given-names" tagx="given-names" title="given-names">I. T.</span></span></span> (<span class="year" tagx="year" title="year">2002</span>). <span class="mixed-article-title" title="mixed-article-title">Antioxidant and lysosomotropic properties of acridine-propranolol: Protection against oxidative endothelial cell injury</span>. <span class="source" tagx="source" title="source"><i>Journal of Molecular and Cellular Cardiology</i></span>, (<span class="issue" tagx="issue" title="issue">2</span>), <span class="fpage" tagx="fpage" title="fpage">129</span>â€"<span class="lpage" tagx="lpage" title="lpage">137</span>. <span class="pub-id"><a href="https://dx.doi.org/10.1056/NEJMoa2001282">10.1056/NEJMoa2001282</a></span><span class="pub-id"><a href="https://dx.doi.org/10.1006/jmcc.2001.1495">10.1006/jmcc.2001.1495</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11851353">11851353</a></span></span></li> <li tag="ref"><a name="CIT0007" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Friesner</span><span class="given-names" tagx="given-names" title="given-names">R. A.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Murphy</span><span class="given-names" tagx="given-names" title="given-names">R. B.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Repasky</span><span class="given-names" tagx="given-names" title="given-names">M. P.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Frye</span><span class="given-names" tagx="given-names" title="given-names">L. L.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Greenwood</span><span class="given-names" tagx="given-names" title="given-names">J. R.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Halgren</span><span class="given-names" tagx="given-names" title="given-names">T. A.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sanschagrin</span><span class="given-names" tagx="given-names" title="given-names">P. C.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mainz</span><span class="given-names" tagx="given-names" title="given-names">D. T.</span></span></span> (<span class="year" tagx="year" title="year">2006</span>). <span class="mixed-article-title" title="mixed-article-title">Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes</span>. <span class="source" tagx="source" title="source"><i>Journal of Medicinal Chemistry</i></span>, (<span class="issue" tagx="issue" title="issue">21</span>), <span class="fpage" tagx="fpage" title="fpage">6177</span>â€"<span class="lpage" tagx="lpage" title="lpage">6196</span>. <span class="pub-id"><a href="https://dx.doi.org/10.1021/jm051256o">10.1021/jm051256o</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17034125">17034125</a></span></span></li> <li tag="ref"><a name="CIT0008" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Giorgio</span><span class="given-names" tagx="given-names" title="given-names">C. D.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shimi</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Boyer</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Delmas</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Galy</span><span class="given-names" tagx="given-names" title="given-names">J. P.</span></span></span> (<span class="year" tagx="year" title="year">2007</span>). <span class="mixed-article-title" title="mixed-article-title">Synthesis and antileishmanial activity of 6-mono-substituted and 3,6-di-substituted acridines obtained by acylation of proflavine</span>. <span class="source" tagx="source" title="source"><i>European Journal of Medicinal Chemistry</i></span>, (<span class="issue" tagx="issue" title="issue">10</span>), <span class="fpage" tagx="fpage" title="fpage">1277</span>â€"<span class="lpage" tagx="lpage" title="lpage">1284</span>. <span class="pub-id"><a href="https://dx.doi.org/10.1016/j.ejmech.2007.02.010">10.1016/j.ejmech.2007.02.010</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17418916">17418916</a></span></span></li> <li tag="ref"><a name="CIT0009" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Goodell</span><span class="given-names" tagx="given-names" title="given-names">J. R.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Madhok</span><span class="given-names" tagx="given-names" title="given-names">A. A.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hiasa</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ferguson</span><span class="given-names" tagx="given-names" title="given-names">D. M.</span></span></span> (<span class="year" tagx="year" title="year">2006</span>). <span class="mixed-article-title" title="mixed-article-title">Synthesis and evaluation of acridine- and acridone-based anti-herpes agents with topoisomerase activity</span>. <span class="source" tagx="source" title="source"><i>Bioorganic &amp;amp; Medicinal Chemistry</i></span>, (<span class="issue" tagx="issue" title="issue">16</span>), <span class="fpage" tagx="fpage" title="fpage">5467</span>â€"<span class="lpage" tagx="lpage" title="lpage">5480</span>. <span class="pub-id"><a href="https://dx.doi.org/10.1016/j.bmc.2006.04.044">10.1016/j.bmc.2006.04.044</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16713270">16713270</a></span></span></li> <li tag="ref"><a name="CIT0010" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Govindarajan</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Periandy</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Carthigayen</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span></span> (<span class="year" tagx="year" title="year">2012</span>). <span class="mixed-article-title" title="mixed-article-title">FT-IR and FT-Raman spectra, thermo dynamical behavior, HOMO and LUMO, UV, NLO properties, computed frequency estimation analysis and electronic structure calculations on Î±-bromotoluene</span>. <span class="source" tagx="source" title="source"><i>Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy</i></span>, , <span class="fpage" tagx="fpage" title="fpage">411</span>â€"<span class="lpage" tagx="lpage" title="lpage">422</span>. <span class="pub-id"><a href="https://dx.doi.org/10.1016/j.saa.2012.06.028">10.1016/j.saa.2012.06.028</a></span></span></li> <li tag="ref"><a name="CIT0011" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gu</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Han</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span></span> (<span class="year" tagx="year" title="year">2020</span>). <span class="mixed-article-title" title="mixed-article-title">COVID-19: Gastrointestinal manifestations and potential fecal -oral transmission</span>. <span class="source" tagx="source" title="source"><i>Gastroenterology</i></span>, , <span class="fpage" tagx="fpage" title="fpage">1518</span>â€"<span class="lpage" tagx="lpage" title="lpage">1519</span>. <span class="pub-id"><a href="https://dx.doi.org/10.1053/j.gastro.2020.02.054">10.1053/j.gastro.2020.02.054</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32142785">32142785</a></span></span></li> <li tag="ref"><a name="CIT0012" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Guo</span><span class="given-names" tagx="given-names" title="given-names">Z.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mohanty</span><span class="given-names" tagx="given-names" title="given-names">U.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Noehre</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sawyer</span><span class="given-names" tagx="given-names" title="given-names">T. K.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sherman</span><span class="given-names" tagx="given-names" title="given-names">W.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Krilov</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span></span> (<span class="year" tagx="year" title="year">2010</span>). <span class="mixed-article-title" title="mixed-article-title">Probing the alpha-helical structural stability of stapled p53 peptides: Molecular dynamics simulations and analysis</span>. <span class="source" tagx="source" title="source"><i>Chemical Biology &amp;amp; Drug Design</i></span>, (<span class="issue" tagx="issue" title="issue">4</span>), <span class="fpage" tagx="fpage" title="fpage">348</span>â€"<span class="lpage" tagx="lpage" title="lpage">359</span>. <span class="pub-id"><a href="https://dx.doi.org/10.1111/j.1747-0285.2010.00951.x">10.1111/j.1747-0285.2010.00951.x</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20331649">20331649</a></span></span></li> <li tag="ref"><a name="CIT0013" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Holshue</span><span class="given-names" tagx="given-names" title="given-names">M. L.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">DeBolt</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lindquist</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lofy</span><span class="given-names" tagx="given-names" title="given-names">K. H.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wiesman</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bruce</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Spitters</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ericson</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wilkerson</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tural</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Diaz</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cohn</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fox</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Patel</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gerber</span><span class="given-names" tagx="given-names" title="given-names">S. I.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kim</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tong</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lu</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lindstrom</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span>, â€¦ <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pillai</span><span class="given-names" tagx="given-names" title="given-names">S. K.</span></span></span> (<span class="year" tagx="year" title="year">2020</span>). <span class="mixed-article-title" title="mixed-article-title">First case of 2019 novel coronavirus in the United States</span>. <span class="source" tagx="source" title="source"><i>New England Journal of Medicine</i></span>, (<span class="issue" tagx="issue" title="issue">10</span>), <span class="fpage" tagx="fpage" title="fpage">929</span>â€"<span class="lpage" tagx="lpage" title="lpage">936</span>. <span class="pub-id"><a href="https://dx.doi.org/10.1056/NEJMoa2001191">10.1056/NEJMoa2001191</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32004427">32004427</a></span></span></li> <li tag="ref"><a name="CIT0014" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Huang</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ren</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhao</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hu</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span></span> (<span class="year" tagx="year" title="year">2020</span>). <span class="mixed-article-title" title="mixed-article-title">Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China</span>. <span class="source" tagx="source" title="source"><i>Lancet</i></span>, , <span class="fpage" tagx="fpage" title="fpage">497</span>â€"<span class="lpage" tagx="lpage" title="lpage">506</span>. <span class="pub-id"><a href="https://dx.doi.org/10.1016/s0140-6736(20)30183-5">10.1016/s0140-6736(20)30183-5</a></span></span></li> <li tag="ref"><a name="CIT0015" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Huang</span><span class="given-names" tagx="given-names" title="given-names">Q.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Herrmann</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span></span> (<span class="year" tagx="year" title="year">2020</span>). <span class="mixed-article-title" title="mixed-article-title">Fast assessment of human receptor-binding capability of 2019 novel coronavirus (2019-nCoV)</span>. BioRxiv 930537. <span class="pub-id"><a href="https://dx.doi.org/10.1101/2020.02.01.930537">10.1101/2020.02.01.930537</a></span></span></li> <li tag="ref"><a name="CIT0016" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jacobson</span><span class="given-names" tagx="given-names" title="given-names">M. P.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pincus</span><span class="given-names" tagx="given-names" title="given-names">D. L.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rapp</span><span class="given-names" tagx="given-names" title="given-names">C. S.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Day</span><span class="given-names" tagx="given-names" title="given-names">T. J. F.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Honig</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shaw</span><span class="given-names" tagx="given-names" title="given-names">D. E.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Friesner</span><span class="given-names" tagx="given-names" title="given-names">R. A.</span></span></span> (<span class="year" tagx="year" title="year">2004</span>). <span class="mixed-article-title" title="mixed-article-title">A hierarchical approach to all-atom protein loop prediction</span>. <span class="source" tagx="source" title="source"><i>Proteins</i></span>, (<span class="issue" tagx="issue" title="issue">2</span>), <span class="fpage" tagx="fpage" title="fpage">351</span>â€"<span class="lpage" tagx="lpage" title="lpage">367</span>. <span class="pub-id"><a href="https://dx.doi.org/10.1002/prot.10613">10.1002/prot.10613</a></span></span></li> <li tag="ref"><a name="CIT0017" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jorgensen</span><span class="given-names" tagx="given-names" title="given-names">W. L.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chandrasekhar</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Madura</span><span class="given-names" tagx="given-names" title="given-names">J. D.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Impey</span><span class="given-names" tagx="given-names" title="given-names">R. W.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Klein</span><span class="given-names" tagx="given-names" title="given-names">M. L.</span></span></span> (<span class="year" tagx="year" title="year">1983</span>). <span class="mixed-article-title" title="mixed-article-title">Comparison of simple potential functions for simulating liquid water</span>. <span class="source" tagx="source" title="source"><i>The Journal of Chemical Physics</i></span>, (<span class="issue" tagx="issue" title="issue">2</span>), <span class="fpage" tagx="fpage" title="fpage">926</span>â€"<span class="lpage" tagx="lpage" title="lpage">935</span>. <span class="pub-id"><a href="https://dx.doi.org/10.1063/1.445869">10.1063/1.445869</a></span></span></li> <li tag="ref"><a name="CIT0018" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kalirajan</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gaurav</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pandiselvi</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gowramma</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sankar</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span></span> (<span class="year" tagx="year" title="year">2019</span>). <span class="mixed-article-title" title="mixed-article-title">Novel thiazine substituted 9-anilinoacridines: Synthesis, antitumour activity and structure activity relationships</span>. <span class="source" tagx="source" title="source"><i>Anti-Cancer Agents in Medicinal Chemistry</i></span>, (<span class="issue" tagx="issue" title="issue">11</span>), <span class="fpage" tagx="fpage" title="fpage">1350</span>â€"<span class="lpage" tagx="lpage" title="lpage">1358</span>. <span class="pub-id"><a href="https://dx.doi.org/10.2174/1871520619666190408134224">10.2174/1871520619666190408134224</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30961512">30961512</a></span></span></li> <li tag="ref"><a name="CIT0019" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kalirajan</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gowramma</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jubie</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sankar</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span></span> (<span class="year" tagx="year" title="year">2017</span>). <span class="mixed-article-title" title="mixed-article-title">Molecular docking studies and <i>in silico</i> ADMET screening of some novel heterocyclic substituted 9-anilinoacridines as topoisomerase II inhibitors</span>. <span class="source" tagx="source" title="source"><i>JSM Chemistry</i></span>, (<span class="issue" tagx="issue" title="issue">1</span>), <span class="fpage" tagx="fpage" title="fpage">1039</span>â€"<span class="lpage" tagx="lpage" title="lpage">1044</span>.</span></li> <li tag="ref"><a name="CIT0020" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kalirajan</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kulshrestha</span><span class="given-names" tagx="given-names" title="given-names">V.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sankar</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span></span> (<span class="year" tagx="year" title="year">2018</span>). <span class="mixed-article-title" title="mixed-article-title">Synthesis, characterization and evaluation for antitumour activity of some novel oxazine substituted 9-anilinoacridines and their 3D-QSAR studies</span>. <span class="source" tagx="source" title="source"><i>Indian Journal of Pharmaceutical Sciences</i></span>, (<span class="issue" tagx="issue" title="issue">5</span>), <span class="fpage" tagx="fpage" title="fpage">921</span>â€"<span class="lpage" tagx="lpage" title="lpage">929</span>. <span class="pub-id"><a href="https://dx.doi.org/10.4172/pharmaceutical-sciences.1000439">10.4172/pharmaceutical-sciences.1000439</a></span></span></li> <li tag="ref"><a name="CIT0021" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kalirajan</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kulshrestha</span><span class="given-names" tagx="given-names" title="given-names">V.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sankar</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jubie</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span></span> (<span class="year" tagx="year" title="year">2012</span>). <span class="mixed-article-title" title="mixed-article-title">Docking studies, synthesis, characterization of some novel oxazine substituted 9-anilinoacridine derivatives and evaluation for their antioxidant and anticancer activities as topoisomerase II inhibitors</span>. <span class="source" tagx="source" title="source"><i>European Journal of Medicinal Chemistry</i></span>, , <span class="fpage" tagx="fpage" title="fpage">217</span>â€"<span class="lpage" tagx="lpage" title="lpage">224</span>. <span class="pub-id"><a href="https://dx.doi.org/10.1016/j.ejmech.2012.08.025">10.1016/j.ejmech.2012.08.025</a></span></span></li> <li tag="ref"><a name="CIT0022" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kalirajan</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mohammed Rafick</span><span class="given-names" tagx="given-names" title="given-names">M. H.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jubie</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sankar</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span></span> (<span class="year" tagx="year" title="year">2012</span>). <span class="mixed-article-title" title="mixed-article-title">Docking studies, synthesis, characterization and evaluation of their antioxidant and cytotoxic activities of some novel isoxazole substituted 9-anilinoacridine derivatives</span>. <span class="source" tagx="source" title="source"><i>The Scientific World Journal</i></span>, , <span class="fpage" tagx="fpage" title="fpage">1</span>â€"<span class="lpage" tagx="lpage" title="lpage">6</span>. 2012. <span class="pub-id"><a href="https://dx.doi.org/10.1100/2012/165258,">10.1100/2012/165258,</a></span></span></li> <li tag="ref"><a name="CIT0023" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kalirajan</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mohammed Rafick</span><span class="given-names" tagx="given-names" title="given-names">M. H.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sankar</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gowramma</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span></span> (<span class="year" tagx="year" title="year">2018</span>). <span class="mixed-article-title" title="mixed-article-title">Green synthesis of some novel chalcone and isoxazole substituted 9-anilinoacridine derivatives and evaluation of their antimicrobial and larvicidal activities</span>. <span class="source" tagx="source" title="source"><i>Indian Journal of Chemistry</i></span>, , <span class="fpage" tagx="fpage" title="fpage">583</span>â€"<span class="lpage" tagx="lpage" title="lpage">590</span>.</span></li> <li tag="ref"><a name="CIT0024" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kalirajan</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Muralidharan</span><span class="given-names" tagx="given-names" title="given-names">V.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jubie</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gowramma</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gomathy</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sankar</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Elango</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span></span> (<span class="year" tagx="year" title="year">2012</span>). <span class="mixed-article-title" title="mixed-article-title">Synthesis of some novel pyrazole substituted 9-anilinoacridine derivatives and evaluation for their antioxidant and cytotoxic activities</span>. <span class="source" tagx="source" title="source"><i>Journal of Heterocyclic Chemistry</i></span>, (<span class="issue" tagx="issue" title="issue">4</span>), <span class="fpage" tagx="fpage" title="fpage">748</span>â€"<span class="lpage" tagx="lpage" title="lpage">754</span>. <span class="pub-id"><a href="https://dx.doi.org/10.1002/jhet.848">10.1002/jhet.848</a></span></span></li> <li tag="ref"><a name="CIT0025" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kalirajan</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Muralidharan</span><span class="given-names" tagx="given-names" title="given-names">V.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jubie</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sankar</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span></span> (<span class="year" tagx="year" title="year">2013</span>). <span class="mixed-article-title" title="mixed-article-title">Microwave assisted synthesis, characterization and evaluation for their antimicrobial activities of some novel pyrazole substituted 9-anilino acridine derivatives</span>. <span class="source" tagx="source" title="source"><i>International Journal of Health &amp;amp; Allied Sciences</i></span>, (<span class="issue" tagx="issue" title="issue">2</span>), <span class="fpage" tagx="fpage" title="fpage">81</span>â€"<span class="lpage" tagx="lpage" title="lpage">87</span>. <span class="pub-id"><a href="https://dx.doi.org/10.4103/2278-344X.115682">10.4103/2278-344X.115682</a></span></span></li> <li tag="ref"><a name="CIT0026" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kalirajan</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pandiselvi</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gowramma</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Balachandran</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span></span> (<span class="year" tagx="year" title="year">2019</span>). <span class="mixed-article-title" title="mixed-article-title"><i>In-silico</i> design, ADMET screening, MM-GBSA binding free energy of some novel isoxazole substituted 9-anilinoacridines as HER2 inhibitors targeting breast cancer</span>. <span class="source" tagx="source" title="source"><i>Current Drug Research Reviews</i></span>, (<span class="issue" tagx="issue" title="issue">2</span>), <span class="fpage" tagx="fpage" title="fpage">118</span>â€"<span class="lpage" tagx="lpage" title="lpage">128</span>. <span class="pub-id"><a href="https://dx.doi.org/10.2174/2589977511666190912154817">10.2174/2589977511666190912154817</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/31513003">31513003</a></span></span></li> <li tag="ref"><a name="CIT0027" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kalirajan</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rathore</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jubie</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gowramma</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gomathy</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sankar</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span></span> (<span class="year" tagx="year" title="year">2011</span>). <span class="mixed-article-title" title="mixed-article-title">Microwave assisted synthesis of some novel pyrazole substituted benzimidazoles and evaluation of their biological activities</span>. <span class="source" tagx="source" title="source"><i>Indian Journal of Chemistry</i></span>, , <span class="fpage" tagx="fpage" title="fpage">1794</span>â€"<span class="lpage" tagx="lpage" title="lpage">1801</span>. <span class="pub-id"><a href="https://dx.doi.org/10.1002/chin.201216123">10.1002/chin.201216123</a></span></span></li> <li tag="ref"><a name="CIT0028" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kalirajan</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sankar</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jubie</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span>, and., &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gowramma</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span></span> (<span class="year" tagx="year" title="year">2017</span>). <span class="mixed-article-title" title="mixed-article-title">Molecular docking studies and <i>in-silico</i> ADMET screening of some novel oxazine substituted 9-anilinoacridines as topoisomerase II inhibitors</span>. <span class="source" tagx="source" title="source"><i>Indian Journal of Pharmaceutical Education and Research</i></span>, (<span class="issue" tagx="issue" title="issue">1</span>), <span class="fpage" tagx="fpage" title="fpage">110</span>â€"<span class="lpage" tagx="lpage" title="lpage">115</span>. <span class="pub-id"><a href="https://dx.doi.org/10.5530/ijper.51.1.15">10.5530/ijper.51.1.15</a></span></span></li> <li tag="ref"><a name="CIT0029" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kalirajan</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sivakumar</span><span class="given-names" tagx="given-names" title="given-names">S. U.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jubie</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gowramma</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Suresh</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span></span> (<span class="year" tagx="year" title="year">2009</span>). <span class="mixed-article-title" title="mixed-article-title">Synthesis and biological evaluation of some heterocyclic derivatives of chalcones</span>. <span class="source" tagx="source" title="source"><i>International Journal of Chemical Science</i></span>, (<span class="issue" tagx="issue" title="issue">1</span>), <span class="fpage" tagx="fpage" title="fpage">27</span>â€"<span class="lpage" tagx="lpage" title="lpage">34</span>.</span></li> <li tag="ref"><a name="CIT0031" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kapuriya</span><span class="given-names" tagx="given-names" title="given-names">N.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kapuriya</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chou</span><span class="given-names" tagx="given-names" title="given-names">T.-C.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kakadiya</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wu</span><span class="given-names" tagx="given-names" title="given-names">Y.-T.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tsai</span><span class="given-names" tagx="given-names" title="given-names">T.-H.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">Y.-T.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lee</span><span class="given-names" tagx="given-names" title="given-names">T.-C.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shah</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Naliapara</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Su</span><span class="given-names" tagx="given-names" title="given-names">T.-L.</span></span></span> (<span class="year" tagx="year" title="year">2008</span>). <span class="mixed-article-title" title="mixed-article-title">Synthesis and biological activity of stable and potent antitumor agents, aniline nitrogen mustards linked to 9-anilinoacridines via a urea linkage</span>. <span class="source" tagx="source" title="source"><i>Bioorganic &amp;amp; Medicinal Chemistry</i></span>, (<span class="issue" tagx="issue" title="issue">10</span>), <span class="fpage" tagx="fpage" title="fpage">5413</span>â€"<span class="lpage" tagx="lpage" title="lpage">5423</span>. <span class="pub-id"><a href="https://dx.doi.org/10.1016/j.bmc.2008.04.024">10.1016/j.bmc.2008.04.024</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18450456">18450456</a></span></span></li> <li tag="ref"><a name="CIT0032" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Abel</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhu</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cao</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhao</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Friesner</span><span class="given-names" tagx="given-names" title="given-names">R. A.</span></span></span> (<span class="year" tagx="year" title="year">2011</span>). <span class="mixed-article-title" title="mixed-article-title">The VSGB 2.0 model: A next generation energy model for high resolution protein structure modeling</span>. <span class="source" tagx="source" title="source"><i>Proteins</i></span>, (<span class="issue" tagx="issue" title="issue">10</span>), <span class="fpage" tagx="fpage" title="fpage">2794</span>â€"<span class="lpage" tagx="lpage" title="lpage">2812</span>. <span class="pub-id"><a href="https://dx.doi.org/10.1002/prot.23106">10.1002/prot.23106</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21905107">21905107</a></span></span></li> <li tag="ref"><a name="CIT0033" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Llama</span><span class="given-names" tagx="given-names" title="given-names">E. F.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Campo</span><span class="given-names" tagx="given-names" title="given-names">C. D.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Capo</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Anadon</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span></span> (<span class="year" tagx="year" title="year">1989</span>). <span class="mixed-article-title" title="mixed-article-title">Synthesis and antinociceptive activity of 9-phenyl-oxy or 9-acyl-oxy derivatives of xanthene, thioxanthene and acridine</span>. <span class="source" tagx="source" title="source"><i>European Journal of Medicinal Chemistry</i></span>, (<span class="issue" tagx="issue" title="issue">4</span>), <span class="fpage" tagx="fpage" title="fpage">391</span>â€"<span class="lpage" tagx="lpage" title="lpage">396</span>. <span class="pub-id"><a href="https://dx.doi.org/10.1016/0223-5234(89)90083-4">10.1016/0223-5234(89)90083-4</a></span></span></li> <li tag="ref"><a name="CIT0034" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lu</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhao</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span></span> (<span class="year" tagx="year" title="year">2020</span>). <span class="mixed-article-title" title="mixed-article-title">Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding</span>. <span class="source" tagx="source" title="source"><i>Lancet</i></span>, (<span class="issue" tagx="issue" title="issue">10224</span>), <span class="fpage" tagx="fpage" title="fpage">565</span>â€"<span class="lpage" tagx="lpage" title="lpage">574</span>. <span class="pub-id"><a href="https://dx.doi.org/10.1016/S0140-6736(20)3025">10.1016/S0140-6736(20)3025</a></span></span></li> <li tag="ref"><a name="CIT0035" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Martyna</span><span class="given-names" tagx="given-names" title="given-names">G. J.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Klein</span><span class="given-names" tagx="given-names" title="given-names">M. L.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tuckerman</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span></span> (<span class="year" tagx="year" title="year">1992</span>). <span class="mixed-article-title" title="mixed-article-title">Nose- Hoover chains-the canonical ensemble via continuous dynamics</span>. <span class="source" tagx="source" title="source"><i>The Journal of Chemical Physics</i></span>, (<span class="issue" tagx="issue" title="issue">4</span>), <span class="fpage" tagx="fpage" title="fpage">2635</span>â€"<span class="lpage" tagx="lpage" title="lpage">2643</span>. <span class="pub-id"><a href="https://dx.doi.org/10.1063/1.463940">10.1063/1.463940</a></span></span></li> <li tag="ref"><a name="CIT0036" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Martyna</span><span class="given-names" tagx="given-names" title="given-names">G. J.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tobias</span><span class="given-names" tagx="given-names" title="given-names">D. J.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Klein</span><span class="given-names" tagx="given-names" title="given-names">M. L.</span></span></span> (<span class="year" tagx="year" title="year">1994</span>). <span class="mixed-article-title" title="mixed-article-title">Constant-pressure molecular dynamics algorithms</span>. <span class="source" tagx="source" title="source"><i>The Journal of Chemical Physics</i></span>, (<span class="issue" tagx="issue" title="issue">5</span>), <span class="fpage" tagx="fpage" title="fpage">4177</span>â€"<span class="lpage" tagx="lpage" title="lpage">4189</span>. <span class="pub-id"><a href="https://dx.doi.org/10.1063/1.467468">10.1063/1.467468</a></span></span></li> <li tag="ref"><a name="CIT0037" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nadaraj</span><span class="given-names" tagx="given-names" title="given-names">V.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Selvi</span><span class="given-names" tagx="given-names" title="given-names">S. T.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mohan</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span></span> (<span class="year" tagx="year" title="year">2009</span>). <span class="mixed-article-title" title="mixed-article-title">Microwave-induced synthesis and anti-microbial activities of 7,10,11,12-tetrahydrobenzo[c]acridin-8(9H)-one derivatives</span>. <span class="source" tagx="source" title="source"><i>European Journal of Medicinal Chemistry</i></span>, (<span class="issue" tagx="issue" title="issue">3</span>), <span class="fpage" tagx="fpage" title="fpage">976</span>â€"<span class="lpage" tagx="lpage" title="lpage">980</span>. <span class="pub-id"><a href="https://dx.doi.org/10.1016/j.ejmech.2008.07.004">10.1016/j.ejmech.2008.07.004</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18718695">18718695</a></span></span></li> <li tag="ref"><a name="CIT0040" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rastogi</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chang</span><span class="given-names" tagx="given-names" title="given-names">J.-Y.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pan</span><span class="given-names" tagx="given-names" title="given-names">W.-Y.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">C.-H.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chou</span><span class="given-names" tagx="given-names" title="given-names">T.-C.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">L.-T.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Su</span><span class="given-names" tagx="given-names" title="given-names">T.-L.</span></span></span> (<span class="year" tagx="year" title="year">2002</span>). <span class="mixed-article-title" title="mixed-article-title">Antitumor AHMA linked to DNA minor groove binding agents: Synthesis and biological evaluation</span>. <span class="source" tagx="source" title="source"><i>Journal of Medicinal Chemistry</i></span>, (<span class="issue" tagx="issue" title="issue">20</span>), <span class="fpage" tagx="fpage" title="fpage">4485</span>â€"<span class="lpage" tagx="lpage" title="lpage">4493</span>. <span class="pub-id"><a href="https://dx.doi.org/10.1021/jm0200714">10.1021/jm0200714</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12238927">12238927</a></span></span></li> <li tag="ref"><a name="CIT0041" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Recanatini</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cavalli</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Belluti</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Piazzi</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rampa</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bisi</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gobbi</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Valenti</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Andrisano</span><span class="given-names" tagx="given-names" title="given-names">V.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bartolini</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cavrini</span><span class="given-names" tagx="given-names" title="given-names">V.</span></span></span> (<span class="year" tagx="year" title="year">2000</span>). <span class="mixed-article-title" title="mixed-article-title">SAR of 9-amino-1,2,3,4-tetrahydroacridine-based acetylcholinesterase inhibitors: synthesis, enzyme inhibitory activity, QSAR, and structure-based CoMFA of tacrine analogues</span> . <span class="source" tagx="source" title="source"><i>Journal of Medicinal Chemistry</i></span>, (<span class="issue" tagx="issue" title="issue">10</span>), <span class="fpage" tagx="fpage" title="fpage">2007</span>â€"<span class="lpage" tagx="lpage" title="lpage">2018</span>. <span class="pub-id"><a href="https://dx.doi.org/10.1021/jm990971t">10.1021/jm990971t</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/10821713">10821713</a></span></span></li> <li tag="ref"><a name="CIT0042" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sastry</span><span class="given-names" tagx="given-names" title="given-names">G. M.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Adzhigirey</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Day</span><span class="given-names" tagx="given-names" title="given-names">T.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Annabhimoju</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sherman</span><span class="given-names" tagx="given-names" title="given-names">W.</span></span></span> (<span class="year" tagx="year" title="year">2013</span>). <span class="mixed-article-title" title="mixed-article-title">Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments</span>. <span class="source" tagx="source" title="source"><i>Journal of Computer-Aided Molecular Design</i></span>, (<span class="issue" tagx="issue" title="issue">3</span>), <span class="fpage" tagx="fpage" title="fpage">221</span>â€"<span class="lpage" tagx="lpage" title="lpage">234</span>. <span class="pub-id"><a href="https://dx.doi.org/10.1007/s10822-013-9644-8">10.1007/s10822-013-9644-8</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23579614">23579614</a></span></span></li> <li tag="ref"><a name="CIT0043" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sondhi</span><span class="given-names" tagx="given-names" title="given-names">S. M.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Johar</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nirupama</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sukla</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Raghubir</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dastidar</span><span class="given-names" tagx="given-names" title="given-names">S. G.</span></span></span> (<span class="year" tagx="year" title="year">2002</span>). <span class="mixed-article-title" title="mixed-article-title">Synthesis of sulpha drug acridine derivatives and their evaluation for anti-anflammatory, analgesic and anticancer activity</span>. <span class="source" tagx="source" title="source"><i>Indian Journal of Chemistry</i></span>, , <span class="fpage" tagx="fpage" title="fpage">2659</span>â€"<span class="lpage" tagx="lpage" title="lpage">2666</span>.</span></li> <li tag="ref"><a name="CIT0044" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Song</span><span class="given-names" tagx="given-names" title="given-names">Z.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xu</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bao</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yu</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Qu</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhu</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhao</span><span class="given-names" tagx="given-names" title="given-names">W.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Han</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Qin</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span></span> (<span class="year" tagx="year" title="year">2019</span>). <span class="mixed-article-title" title="mixed-article-title">From SARS to MERS, thrusting coronaviruses into the spotlight</span>. <span class="source" tagx="source" title="source"><i>Viruses</i></span>, (<span class="issue" tagx="issue" title="issue">1</span>), <span class="fpage" tagx="fpage" title="fpage">59</span><span class="pub-id"><a href="https://dx.doi.org/10.3390/v11010059">10.3390/v11010059</a></span></span></li> <li tag="ref"><a name="CIT0045" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">To</span><span class="given-names" tagx="given-names" title="given-names">K. K.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tsang</span><span class="given-names" tagx="given-names" title="given-names">O. T.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chik-Yan Yip</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span></span> (<span class="year" tagx="year" title="year">2020</span>). <span class="mixed-article-title" title="mixed-article-title">Consistent detection of 2019 novel coronavirus in saliva</span>. <span class="source" tagx="source" title="source"><i>Clinical Infectious Diseases</i></span>. <span class="pub-id"><a href="https://dx.doi.org/10.1093/cid/ciaa149">10.1093/cid/ciaa149</a></span></span></li> <li tag="ref"><a name="CIT0046" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wakelin</span><span class="given-names" tagx="given-names" title="given-names">L. P. G.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bu</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Eleftheriou</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Parmar</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hayek</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Stewart</span><span class="given-names" tagx="given-names" title="given-names">B. W.</span></span></span> (<span class="year" tagx="year" title="year">2003</span>). <span class="mixed-article-title" title="mixed-article-title">Bisintercalating threading diacridines: Relationships between DNA binding, cytotoxicity, and cell cycle arrest</span>. <span class="source" tagx="source" title="source"><i>Journal of Medicinal Chemistry</i></span>, (<span class="issue" tagx="issue" title="issue">26</span>), <span class="fpage" tagx="fpage" title="fpage">5790</span>â€"<span class="lpage" tagx="lpage" title="lpage">5802</span>. <span class="pub-id"><a href="https://dx.doi.org/10.1021/jm030253d">10.1021/jm030253d</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14667232">14667232</a></span></span></li> <li tag="ref"><a name="CIT0047" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hu</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hu</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhu</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xiang</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cheng</span><span class="given-names" tagx="given-names" title="given-names">Z.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xiong</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhao</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Peng</span><span class="given-names" tagx="given-names" title="given-names">Z.</span></span></span> (<span class="year" tagx="year" title="year">2020</span>). <span class="mixed-article-title" title="mixed-article-title">Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China</span>. <span class="source" tagx="source" title="source"><i>JAMA</i></span>, (<span class="issue" tagx="issue" title="issue">11</span>), <span class="fpage" tagx="fpage" title="fpage">1061</span><span class="pub-id"><a href="https://dx.doi.org/10.1001/jama.2020.1585">10.1001/jama.2020.1585</a></span></span></li> <li tag="ref"><a name="CIT0048" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kang</span><span class="given-names" tagx="given-names" title="given-names">Z. J.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gong</span><span class="given-names" tagx="given-names" title="given-names">H. Y.</span></span></span> (<span class="year" tagx="year" title="year">2020</span>). <span class="mixed-article-title" title="mixed-article-title">The digestive system is a potential route of 2019-nCov infection: A bioinformatics analysis based on single-cell transcriptomes</span>. BioRxiv 927806. <span class="pub-id"><a href="https://dx.doi.org/10.1101/2020.01.30.927806">10.1101/2020.01.30.927806</a></span></span></li> <li tag="ref"><a name="CIT0049" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhou</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hou</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shen</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Huang</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Martin</span><span class="given-names" tagx="given-names" title="given-names">W.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cheng</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span></span> (<span class="year" tagx="year" title="year">2020</span>). <span class="mixed-article-title" title="mixed-article-title">Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2</span>. <span class="source" tagx="source" title="source"><i>Cell Discovery</i></span>, , <span class="fpage" tagx="fpage" title="fpage">14</span>â€"<span class="lpage" tagx="lpage" title="lpage">19</span>. <span class="pub-id"><a href="https://dx.doi.org/10.1038/s41421-020-0153-3">10.1038/s41421-020-0153-3</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32194980">32194980</a></span></span></li> <li tag="ref"><a name="CIT0050" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhou</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">X.-L.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">X.-G.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hu</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">W.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Si</span><span class="given-names" tagx="given-names" title="given-names">H.-R.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhu</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Huang</span><span class="given-names" tagx="given-names" title="given-names">C.-L.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">H.-D.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Luo</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Guo</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jiang</span><span class="given-names" tagx="given-names" title="given-names">R.-D.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">M.-Q.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shen</span><span class="given-names" tagx="given-names" title="given-names">X.-R.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span>, â€¦ <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shi</span><span class="given-names" tagx="given-names" title="given-names">Z.-L.</span></span></span> (<span class="year" tagx="year" title="year">2020</span>). <span class="mixed-article-title" title="mixed-article-title">A pneumonia outbreak associated with a new coronavirus of probable bat origin</span>. <span class="source" tagx="source" title="source"><i>Nature</i></span>, (<span class="issue" tagx="issue" title="issue">7798</span>), <span class="fpage" tagx="fpage" title="fpage">270</span>â€"<span class="lpage" tagx="lpage" title="lpage">273</span>. <span class="pub-id"><a href="https://dx.doi.org/10.1038/s41586-020-2012-7,">10.1038/s41586-020-2012-7,</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32015507">32015507</a></span></span></li> </ul> </div> </div>  </body></html>